[1]
K. Zaher, N. E. Masango, W. Sobhi, K. E. Kanouni, A. Semmeq, and Y. Benguerba, “In-silico Study of the Developed Hydroxychloroquine-based ACE2 Inhibitor Molecules Against COVID-19: Molecular Modeling and Docking”, Eng. Technol. Appl. Sci. Res., vol. 11, no. 4, pp. 7336–7342, Aug. 2021.